| 19.04.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.04.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.04.2024 08:46 | GSK | TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment | Alliance |
| 17.04.2024 07:05 | GSK | GSK announces additional EAGLE-1 results | RNS |
| 17.04.2024 07:00 | GSK | Results from long-term data relating to Shingrix | RNS |
| 16.04.2024 14:11 | GSK | Amendment - Director/PDMR Shareholding | RNS |
| 16.04.2024 08:59 | GSK | GSK's latest meningitis vaccine accepted for review by US regulator | Alliance |
| 16.04.2024 07:00 | GSK | FDA accepts GSK meningitis vaccine candidate file | RNS |
| 15.04.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 08.04.2024 09:13 | ELM, LRE, HSX | LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'
| Alliance |
| 04.04.2024 13:08 | SNX, TRI, TTG | UK dividends calendar - next 7 days | Alliance |
| 04.04.2024 12:05 | GSK | Replacement - Total Voting Rights | RNS |
| 02.04.2024 15:00 | GSK | Total Voting Rights | RNS |
| 26.03.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 25.03.2024 13:00 | GSK | Notice of AGM | RNS |
| 22.03.2024 16:20 | GSK | Transfer of Treasury Shares | RNS |
| 22.03.2024 15:36 | GSK | Director/PDMR Shareholding | RNS |
| 19.03.2024 09:21 | RMV, CTEC, GSK | LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry | Alliance |
| 18.03.2024 09:30 | GSK | New Phase III Jemperli data in endometrial cancer | RNS |
| 18.03.2024 08:47 | GSK, HLN | TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon | Alliance |
| 18.03.2024 08:47 | GSK | GSK says Jemperli combination gets good results for endometrial cancer | Alliance |
| 13.03.2024 15:48 | GSK | Director/PDMR Shareholding | RNS |
| 08.03.2024 17:12 | GSK | Board Committee Change | RNS |
| 07.03.2024 09:38 | GSK | GSK observes positive data in Blenrep trial for blood cancer treatment | Alliance |
| 07.03.2024 07:00 | GSK | GSK announces positive Blenrep DREAMM-8 results | RNS |
| 06.03.2024 16:00 | GSK | ViiV LAI vs oral SOC data in adherence-challenged | RNS |
| 05.03.2024 17:24 | GSK | GSK Annual Report 2023 on Form 20-F | RNS |
| 05.03.2024 11:03 | GSK | GSK says ViiV's cabotegravir study supports longer HIV dose interval | Alliance |
| 05.03.2024 07:00 | GSK | New ViiV LA formulation potential 4-month dosing | RNS |
| 01.03.2024 15:00 | GSK | Total Voting Rights | RNS |
| 01.03.2024 12:15 | GSK | GSK publishes Annual Report 2023 | RNS |
| 29.02.2024 09:44 | GSK | TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement | Alliance |
| 29.02.2024 07:05 | GSK | Directorate Change | RNS |
| 29.02.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 26.02.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 26.02.2024 08:25 | GSK | GSK gonorrhoea treatment achieves efficacy endpoint in latest trial | Alliance |
| 26.02.2024 07:00 | GSK | GSK announces positive EAGLE-1 headline results | RNS |
| 22.02.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 21.02.2024 09:47 | GSK | GSK reports encouraging results for ViiV's Cabenuva HIV treatment | Alliance |
| 21.02.2024 07:00 | GSK | ViiV LAI superior to orals in adherence-challenged | RNS |
| 20.02.2024 15:10 | HLN, GSK, WTB | PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky | Alliance |
| 20.02.2024 09:01 | GSK | Julie Brown - External Appointment | RNS |
| 20.02.2024 08:55 | GSK, DGE | IN BRIEF: Diageo welcomes GSK's CFO as non-executive director | Alliance |
| 19.02.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 15.02.2024 15:32 | GSK | Director/PDMR Shareholding | RNS |
| 15.02.2024 14:44 | BRCK, WTAN, VMUK | UK dividends calendar - next 7 days | Alliance |
| 15.02.2024 09:45 | AWE, CBG, IHP | LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises | Alliance |
| 15.02.2024 08:49 | GSK | GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio | Alliance |
| 15.02.2024 07:00 | GSK | GSK completes acquisition of Aiolos Bio | RNS |
| 13.02.2024 16:45 | GSK | Director/PDMR Shareholding - Replacement | RNS |
| 13.02.2024 15:40 | GSK | Director/PDMR Shareholding | RNS |
| 13.02.2024 15:35 | GSK | Director/PDMR Shareholding | RNS |
| 13.02.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 13.02.2024 09:32 | ITM, XPS, PHP | LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions | Alliance |
| 12.02.2024 15:39 | GSK | Director/PDMR Shareholding | RNS |
| 12.02.2024 15:38 | GSK | Director/PDMR Shareholding | RNS |
| 12.02.2024 15:26 | GSK | Director/PDMR Shareholding | RNS |
| 12.02.2024 08:35 | GSK | TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation | Alliance |
| 12.02.2024 07:00 | GSK | US FDA Fast Track designation for bepirovirsen | RNS |
| 09.02.2024 09:15 | GSK, SSE, AZN | LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell' | Alliance |
| 06.02.2024 08:51 | GSK | TOP NEWS: GSK reports positive news on trio of high profile products | Alliance |
| 01.02.2024 09:27 | GSK | TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case | Alliance |
| 01.02.2024 09:03 | EZJ, PETS, CWK | LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet | Alliance |
| 31.01.2024 09:13 | GSK | TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down | Alliance |
| 31.01.2024 07:00 | GSK | Final Results | RNS |
| 29.01.2024 08:51 | GSK | GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara | Alliance |
| 29.01.2024 07:05 | GSK | EMA accepts Arexvy filing for adults 50-59 at risk | RNS |
| 29.01.2024 07:00 | GSK | European Commission authorises Omjjara in the EU | RNS |
| 24.01.2024 14:34 | NWF, ITM, GSK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 22.01.2024 09:34 | GSK, INVP, ONT | IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO | Alliance |
| 19.01.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 18.01.2024 17:00 | GSK, HLN | Holding(s) in Company | RNS |
| 17.01.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.01.2024 09:38 | HLN, GSK | UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2% | Alliance |
| 17.01.2024 07:00 | GSK | GSK completes sale of shares in Haleon plc | RNS |
